4//SEC Filing
Wallace Eli M. 4
Accession 0001193125-26-003027
CIK 0001869105other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 7:22 PM ET
Size
5.6 KB
Accession
0001193125-26-003027
Insider Transaction Report
Form 4
Wallace Eli M.
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2026-01-01+1,114,400→ 1,114,400 totalExercise: $12.52Exp: 2035-12-31→ Common Stock (1,114,400 underlying)
Footnotes (1)
- [F1]69,650 of the shares underlying the option vested on January 2, 2026. Thereafter, 1/48th of the shares underlying the option will vest monthly, with full vesting scheduled for October 2, 2029, subject to the Reporting Person's continuous service with the Issuer on each such vesting date.
Documents
Issuer
BridgeBio Oncology Therapeutics, Inc.
CIK 0001869105
Entity typeother
Related Parties
1- filerCIK 0001776352
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 7:22 PM ET
- Size
- 5.6 KB